Publisher
Springer Berlin Heidelberg
Reference116 articles.
1. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double- blind study. Cancer Treat Rep 1985 (69):751–754
2. Deila Cuna GR, Pellegrini A, Piazzi M: Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo- controlled, multicenter study. Exp J Cancer Clin Oncol 1989 (25):1817–1821
3. Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W: Treatment of metastatic prostatic cancer with low-dose prednisone: Evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989 (7):590–597
4. Popiela T, Lucchi R, Giongo F: Methylprednisolone as palliative therapy for female terminal cancer patients. Exp J Cancer Clin Oncol 1989 (25):1823–1829
5. Cassileth PA, Lusk EJ, Torri S, DiNubile N, Gerson SL: Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Int Med 1983 (143):1347–1349